Drug Database
Back to search

France· FR:63053767

FULVESTRANT TEVA 250 mg, solution injectable en seringue préremplie

A fulvestrant product containing fulvestrant, registered in France by TEVA SANTE, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L02BA03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFULVESTRANT TEVA 250 mg, solution inj…ATCL02BA03REGISTER NO.FR:63053767PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fulvestrantAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fulvestrant is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BA03 (fulvestrant), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search fulvestrant products by name

Fulvestrant · ATC L02BA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fulvestrant costs, country by country.

Normalised to the WHO defined daily dose (16.7 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fulvestrant · price per daily dose (16.7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$13.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FULVESTRANT
Manufacturer
TEVA SANTE
Country
France (FR)
ATC code
L02BA03
ATC class
Fulvestrant
Defined daily dose
16.7 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930103005
    2 seringue(s) préremplie(s) en verre de 5 ml avec un piston polypropylène, munies d'un connecteur Luer-Lock avec 2 aiguilles protégées
    EUR 184.67

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for fulvestrant.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fulvestrant against other medicinesHow interaction checks work

Fulvestrant · interactions on record

110 records

  • 1 moderate
  • 109 info

Most severe, free to view

  • Omacetaxine mepesuccinateL01XX40moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fulvestrant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fulvestrant products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Fulvestrant +pharma, Fulvestrant Accord
  • Belgium · Fulvestrant Accord, Fulvestrant Eugia
  • Bulgaria · Fulvestrant Ever Pharma, Fulvestrant Pharmascience
  • Cyprus · Fulvestrant Accord, Fulvestrant Rompharm
  • Czechia · Fulvestrant Accord, Fulvestrant Ever Pharma
  • Germany · Fulvestrant 1 A Pharma, Fulvestrant Abz
  • Denmark · Fulvestrant "stada", Fulvestrant Accord
  • Estonia · Fulvestrant Accord, Fulvestrant Aliud
  • Spain · Afultrant, Ambiful
  • Finland · Fulvestrant Accord, Fulvestrant Ever Pharma
  • United Kingdom (Northern Ireland) · Fulvestrant Accord Healthcare, Fulvestrant Dr. Reddy's
  • Greece · Fulvestrant Accord, Fulvestrant Demo
  • Croatia · Fulvestrant Accord, Fulvestrant Aptapharma
  • Hungary · Fulvestrant Aptapharma, Fulvestrant Elc
  • Ireland · Fulvestrant Accord Healthcare Ireland, Fulvestrant Ever Pharma
  • Iceland · Faslodex, Fulvestrant Accord
  • Italy · Fulvestrant Accord, Fulvestrant Aurobindo
  • Liechtenstein · Faslodex, Fulvestrant Mylan
  • Lithuania · Fulvestrant Aliud, Fulvestrant Orion
  • Luxembourg · Fulvestrant Teva
  • Latvia · Fulvestrant Aliud, Fulvestrant Stada
  • Malta · Fulvestrant Ever Pharma
  • Netherlands · Fulvestrant, Fulvestrant Accord
  • Norway · Faslodex, Fulvestrant Accord
  • Poland · Fulvestrant Eugia, Fulvestrant Ever Pharma
  • Portugal · Ambiful, Cykostra
  • Romania · Falvax, Fulvestrant Accord
  • Sweden · Fulvestrant Accord, Fulvestrant Ever Pharma
  • Slovenia · Fulvestrant Accord, Fulvestrant Aptapharma
  • Slovakia · Fulvestrant Accord, Fulvestrant Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd3cc60d-363b-4917-bccd-576d02f71bc1
GET /v1/drugs/fd3cc60d-363b-4917-bccd-576d02f71bc1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63053767",
  "date_amm": "2017-07-20",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "FULVESTRANT",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intramusculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about fulvestrant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console